TD Securities initiated coverage of Cronos Group (CRON) with a Buy rating and C$4.50 price target Cronos, which has “some of the most iconic Canadian cannabis brands on the market, is well-positioned to improve profitability as it scales the top-line with a lean operating cost base and leading cultivation practices, the analyst tells investors.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRON:
- Cronos Group launches all-in-one vape ‘Spinach PUFFERZ’
- Cronos Group initiated with a Buy at Canaccord
- Trump Trade: U.S. delays tariffs on Chinese semiconductors